Viracta Therapeutics Cash from Investing (TTM) Insights

Viracta Therapeutics Inc (VIRX)

0.761 -0.04 (-4.85%) USD | NASDAQ | May 22, 16:00

0.761 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
March 31, 2024	36.54M
December 31, 2023	15.00M
September 30, 2023	5.525M
June 30, 2023	-55.63M
March 31, 2023	-61.22M
December 31, 2022	-53.87M
September 30, 2022	-53.68M

Date	Value
June 30, 2022	-5.853M
March 31, 2022	-4.252M
December 31, 2021	12.89M
September 30, 2021	12.91M
June 30, 2021	17.13M
March 31, 2021	17.09M
December 31, 2020	-0.055M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-61.22M

Minimum

Mar 2023

36.54M

Maximum

Mar 2024

-8.391M

Average

2.735M

Median

Cash from Investing (TTM) Benchmarks